There are so many possibilities, and they have been expressed on this and the google boards. After a couple years I sold my remaining shares today to move to another stock, so I expect good news near-term and $8pps. Of course I will continue to monitor. Good luck to everyone.
ace and acimers first, my near-term and $8 pps was a joke regarding cris, because sometimes when i sell a stock it then takes off. i was not referring to gale, the stock i moved more money into today. i will not try to sell the stock. anyone who is interested will do the research, pro and con - propthink takedown/shorting and subsequent lawsuit by gale, for example. this is a tremendous example of an all or nothing scenario. neuvax will either fail, or be a great drug to prevent/delay recurrence of np+, her2- breast cancer. my feeling is this is a stock only for investors who have money they are willing to lose.
docihi - sorry to hear that you are departing your CRIS investment. I do want to thank you for your helpful input on this board over the past several years. Please do drop back to tell us where else you are roaming in biotech.
derek - today an ASCO abstract came out with a 'no statistical effect' for Erivedge in esophageal cancer. A disappointment, and with all of the recent directional shifts, I'm sure more than a few hands sold out. I look at 2013 and see Euro approval, 907 progress, and at the end ... Operable BCC as potential high points - but right now, the sentiment is low.